Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China
Author:
Publisher
Elsevier BV
Subject
Microbiology (medical),Immunology,Immunology and Allergy,Microbiology
Reference25 articles.
1. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013
2. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network;Zhang;Antimicrob Agents Chemother,2018
3. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria;Nordmann;Lancet Infect Dis,2009
4. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016);Wang;Clin Infect Dis,2018
5. Efficacy of ceftazidime–avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae;Alraddadi;BMC Infect Dis,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetic parameters of CAZ–AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care;Journal of Chemotherapy;2024-01-30
2. All Roads Lead to Rome: Enhancing the Probability of Target Attainment with Different Pharmacokinetic/Pharmacodynamic Modelling Approaches;Antibiotics;2023-04-01
3. Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades;Annals of Medicine;2023-03
4. Evaluation of the Efficacy of Optimized Two-Step-Administration Therapy with Ceftazidime/Avibactam for Treating Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Pulmonary Infections: a Pharmacokinetic/Pharmacodynamic Analysis;Japanese Journal of Infectious Diseases;2023-01-31
5. Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review;Antibiotics;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3